Promescent vs UrWay Health

Choose Promescent if: You want immediate over-the-counter PE treatment without prescription requirements or doctor consultations, prefer on-demand topical solution (Delay Spray) applied only when needed vs daily medication, need fastest access to PE treatment (purchase directly online/retail within days), have mild-to-moderate PE suitable for topical approach, value localized action and no systemic medication, want established PE specialist brand (11+ years operating, FDA-reviewed, retail presence), prefer proven clinical validation and brand recognition over newer startups, or have occasional sexual activity making daily medication unnecessary and OTC spray more practical.

Choose UrWay Health if: You have moderate-to-severe premature ejaculation requiring evidence-based prescription SSRI treatment with strongest clinical efficacy, prioritize lowest-cost prescription sertraline option in market ($25-65/month, significantly cheaper than competitors), accept prescription requirements and consultation process for budget savings, need multi-category platform addressing PE plus weight loss (GLP-1 medications), are comfortable with newer startup (2 years operating) prioritizing affordability over brand maturity, want daily medication approach for continuous PE control vs on-demand topical applications, or value cost savings over established brand reputation and retail accessibility.

Bottom line: Promescent and UrWay Health represent different PE treatment philosophies - established OTC accessibility vs budget prescription affordability - with fundamental tradeoffs in brand maturity, convenience, and cost. Promescent excels at immediate non-prescription access through FDA-reviewed lidocaine Delay Spray ($22-35 per bottle, 5-10 minute onset, localized action, 11+ years market presence, retail distribution) eliminating prescription barriers for mild-moderate PE, while also offering prescription sertraline ($49-79/month) matching SSRI efficacy but at higher cost than UrWay. UrWay Health delivers budget-focused prescription-only PE treatment through generic sertraline ($25-65/month, 2-4x ejaculation improvement, $288-576 annual savings vs Promescent prescription) prioritizing affordability over brand recognition, embedded within limited multi-category platform adding weight loss services but lacking specialized PE expertise of dedicated platforms. For immediate OTC access with established brand trust, Promescent provides practical topical solution with retail availability and clinical validation. For lowest-cost prescription SSRI treatment accepting newer startup, UrWay offers significant budget savings over competitors. Promescent targets occasional users and those wanting non-prescription topical options, UrWay targets cost-conscious consumers needing daily SSRI medication at budget prices. Brand maturity heavily favors Promescent (11 years vs 2 years, FDA-reviewed, retail presence), while prescription pricing heavily favors UrWay ($25-65 vs $49-79). For occasional use, Promescent OTC spray most cost-effective ($22-35 per bottle); for regular prescription use, UrWay offers best value despite being newer platform.